112 related articles for article (PubMed ID: 6367331)
1. Insulin resistance in uraemic insulin-dependent diabetics. Effect of dialysis therapy as assessed by the artificial endocrine pancreas.
Schmitz O; Alberti KG; Orskov H
Acta Endocrinol (Copenh); 1984 Mar; 105(3):371-8. PubMed ID: 6367331
[TBL] [Abstract][Full Text] [Related]
2. Effect of haemodialysis on insulin requirements in uraemic diabetic patients. Studies with the artificial beta-cell.
Schmitz O
Proc Eur Dial Transplant Assoc; 1983; 19():769-72. PubMed ID: 6348766
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
Schmitz O; Hjøllund E; Alberti KG; Orskov H; Beck-Nielsen H
Diabetes Res; 1985 Mar; 2(2):57-63. PubMed ID: 4042532
[TBL] [Abstract][Full Text] [Related]
4. Absence of diurnal plasma prolactin rhythm in diabetic and non-diabetic uraemic patients.
Schmitz O
Acta Endocrinol (Copenh); 1984 Feb; 105(2):173-8. PubMed ID: 6538055
[TBL] [Abstract][Full Text] [Related]
5. Renin, growth hormone and insulin in hemodialyzed uremic diabetics.
Avram MM
Artif Organs; 1978 Nov; 2(4):382-5. PubMed ID: 743011
[TBL] [Abstract][Full Text] [Related]
6. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
[TBL] [Abstract][Full Text] [Related]
7. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
Schmitz O
Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
[TBL] [Abstract][Full Text] [Related]
8. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
[TBL] [Abstract][Full Text] [Related]
9. Pre-diabetes and arterial stiffness in uraemic patients.
Hornum M; Clausen P; Kjaergaard J; Hansen JM; Mathiesen ER; Feldt-Rasmussen B
Nephrol Dial Transplant; 2010 Apr; 25(4):1218-25. PubMed ID: 19846393
[TBL] [Abstract][Full Text] [Related]
10. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis.
Kobayashi S; Maejima S; Ikeda T; Nagase M
Nephrol Dial Transplant; 2000 Jan; 15(1):65-70. PubMed ID: 10607769
[TBL] [Abstract][Full Text] [Related]
11. [Blood-sugar-controlled insulin infusion systems for rapid adjustment of insulin-dependent diabetics (author's transl)].
Beyer J; Becker G; Schulz G; Gaberle E; Wolf E; Hassinger W; Cordes U
Dtsch Med Wochenschr; 1981 Dec; 106(49):1644-9. PubMed ID: 7030687
[TBL] [Abstract][Full Text] [Related]
12. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
Iglesias P; Grande C; Méndez J; Fernandez-Reyes MJ; Bajo MA; Selgas R; Díez JJ
Adv Perit Dial; 1996; 12():71-6. PubMed ID: 8865877
[TBL] [Abstract][Full Text] [Related]
13. 24-h blood glucose pattern in type I and type II diabetics after oral treatment with pentoxifylline as assessed by artificial endocrine pancreas.
Raptis S; Mitrakou A; Hadjidakis D; Diamantopoulos E; Anastasiou C; Fountas A; Müller R
Acta Diabetol Lat; 1987; 24(3):181-92. PubMed ID: 3687311
[TBL] [Abstract][Full Text] [Related]
14. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
16. Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.
Trelewicz P; Grzeszczak W; Drabczyk R
Int Urol Nephrol; 1994; 26(1):117-23. PubMed ID: 8026916
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
[TBL] [Abstract][Full Text] [Related]
18. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
[TBL] [Abstract][Full Text] [Related]
19. Characterization of insulin resistance in type I diabetes.
Kerner W; Navascués I; von Schrenck T; Fussgänger R; Arias P; Pfeiffer EF
Klin Wochenschr; 1985 Jun; 63(12):545-53. PubMed ID: 3897693
[TBL] [Abstract][Full Text] [Related]
20. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
Marttinen A; Pasternack A; Koivula T
Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
